8/10/2011 | IGLM | Beckman Coulter redeems $36.19 million 7.05% debentures due 2026
|
8/9/2011 | CVLM | Beckman Coulter holders may put 2.5% convertibles until month-end; most holders opt for conversion
|
7/13/2011 | CVIG | Moody's: Beckman stable
|
6/30/2011 | CVLM | Beckman Coulter holders may put 2.5% convertibles after control change
|
6/30/2011 | IGLM | Beckman Coulter calls four note series after acquisition by Danaher
|
3/21/2011 | CV | Market Commentary: SBA expands some, Clearwire lower on AT&T/T-Mobile announcement; Beckman, Best Buy steady
|
2/16/2011 | CV | Market Commentary: Convertibles lackluster; Ciena trades mixed to higher; Radian gains; USEC mostly unchanged
|
2/11/2011 | CV | Market Commentary: Molycorp drops; called Ford preferreds 'come in' a couple of points; Wright Medical jumps
|
2/9/2011 | CV | Market Commentary: Hedge players win on Wyndham tender; Kodak reverses course; MF Global steady to higher
|
2/8/2011 | CV | Market Commentary: MF Global edges higher on debt; Beckman active; Molina adds outright with stock gains
|
2/8/2011 | CVIG | Moody's may up Beckman
|
2/8/2011 | CVIG | Fitch puts Beckman on positive watch
|
2/7/2011 | CVIG | Danaher to buy Beckman Coulter using cash, equity, new, assumed debt
|
2/7/2011 | CV | Market Commentary: Beckman 'comes in' on hedge; Chesapeake up on planned asset sale talk; MF Global on tap
|
2/7/2011 | CVIG | S&P: Beckman Coulter on watch
|
1/5/2011 | CV | Market Commentary: ADM, Beckman Coulter active in dealer-to-dealer trade; Newmont Mining slips; WebMD on tap
|
12/13/2010 | CVIG | Moody's: Beckman Coulter view to negative
|
12/10/2010 | CV | Market Commentary: New HeartWare surges; ShengdaTech quiet on debut; Beckman Coulter comes in on sale talk
|
12/10/2010 | CVIG | S&P puts Beckman on developing watch
|
9/8/2010 | CV | Market Commentary: Alliant Techsystems gains; Beckman Coulter active, steady; Ciena quiet after earnings news
|
9/3/2010 | CV | Market Commentary: Convertibles quiet, ride stronger equity markets; SanDisk holds on to gains; Agco improves
|
8/9/2010 | CV | Market Commentary: Convertibles quiet; Beckman Coulter recoups a little; King Pharmaceuticals down a point
|
7/26/2010 | CV | Market Commentary: Gilead active, weaker on new notes; AMD mostly quiet, higher on tender; Alcoa trades in line
|
7/23/2010 | CVIG | S&P: Beckman Coulter unaffected
|
4/12/2010 | CV | Market Commentary: Convertibles mixed; Transocean, Beckman active; ON Semi's 0s add on incentive; Quanta off
|
3/25/2010 | CVIG | Moody's: No change for Beckman Coulter
|
3/23/2010 | CV | Market Commentary: Kaiser higher bid in the gray, deal upsized; Beckman Coulter holds up; Cemex paper on tap
|
2/26/2010 | CVIG | Fitch affirms Beckman Coulter
|
12/21/2009 | CV | Market Commentary: Convertibles mostly quiet; Chattem jumps on M&A news; Beckman slightly higher in trade
|
5/18/2009 | CVIG | S&P gives Beckman Coulter notes BBB
|
5/18/2009 | CVIG | Moody's rates Beckman Coulter notes Baa3
|
5/18/2009 | CVIG | Fitch rates Beckman Coulter notes BBB
|
5/18/2009 | IG | New Issue: Beckman Coulter prices $500 million senior notes in six-, 10-year tranches
|
5/18/2009 | IG | Market Commentary: ConocoPhillips, Kellogg, Aflac, EOG, Principal, Beckman Coulter deals price; new bonds gain
|
5/7/2009 | IG | Beckman Coulter planning $500 million offering of debt securities
|
2/27/2009 | CVIG | Moody's affirms Beckman Coulter
|
2/27/2009 | CVIG | S&P affirms Beckman Coulter
|
2/27/2009 | CVIG | Fitch affirms Beckman Coulter
|
11/12/2008 | CVIG | Beckman Coulter files automatic shelf registration
|
5/22/2008 | CVIG | Fitch affirms Beckman Coulter
|
5/15/2008 | CVIG | S&P ups Beckman Coulter outlook to stable
|
2/25/2008 | CV | Market Commentary: Level 3 mixed ahead of presentation; GM, Ford in line on reports; Archer Daniels, Beckman Coulter active
|
8/20/2007 | CVIG | Moody's confirms Beckman Coulter
|
6/26/2007 | SS | Market Commentary: Huntsman pressures Lyondell, lifts KMG; Ventana pushes Cepheid; BCE off; Vonage up
|
5/31/2007 | CV | Fitch affirms Beckman Coulter
|
5/21/2007 | CV | S&P affirms Beckman Coulter
|
5/17/2007 | SS | Inverness to acquire Biosite for $92.50 per share in cash tender offer
|
5/15/2007 | SS | Biosite: Latest offer from Inverness superior, Beckman Coulter will not go higher than $90 per share
|
5/15/2007 | SS | Market Commentary: Dow Jones better, Reuters rises; SunTrust lower; 21st Century up; Ingersoll-Rand gains; Biosite off
|
5/10/2007 | SS | Biosite says Inverness' latest proposal could be superior to Beckman Coulter deal
|
5/10/2007 | SS | Market Commentary: Magna rises; Hillenbrand split cheered; Griffon seen breaking up; Back Yard Burgers bounces
|
5/2/2007 | CV | Market Commentary: Beckman Coulter slips on raised bid; Dune gains on debut; Pennsylvania, Epicor, Sinclair quiet in gray
|
5/2/2007 | SS | Beckman Coulter amends Biosite agreement; on par with Inverness Medical offer
|
5/2/2007 | SS | Market Commentary: Cablevision, Bisys gain on buyout offers; Universal eases on uncertainty; Beckman drops on costlier bid
|
4/26/2007 | SS | Biosite to move forward with superior proposal from Inverness; Beckman-Coulter can counter
|
4/26/2007 | SS | Market Commentary: Nacco oscillates; Wendy's gains; Applebee's rises; Biosite bows; Harman up; new Delta slow, low
|
4/20/2007 | SS | Biosite to evaluate revised financing commitment letters from Inverness; Beckman Coulter deal continues
|
4/20/2007 | SS | Market Commentary: Clear Channel off; H&R Block up; Aeroflex rises; Genesco, Foot Locker gain; SLM slides
|
4/18/2007 | SS | Biosite to review revisions from Inverness Medical as Beckman Coulter tender offer continues
|
4/17/2007 | SS | Waiting period expires in Beckman Coulter's acquisition of Biosite; transaction slated to close in May
|
4/10/2007 | SS | Biosite to enter discussions with Inverness Medical; Beckman Coulter tender offer continues
|
4/9/2007 | CV | Market Commentary: Peabody climbs on stock upgrade; Beckman Coulter up as bidding war looms; Conexant slips on warning
|
4/9/2007 | SS | Inverness Medical: Biosite fails to respond to $90-per-share acquisition proposal
|
4/9/2007 | SS | Market Commentary: Mirant boosts power producers; Dow Chemical, Devon higher; Herbalife slides; Affordable up
|
4/5/2007 | SS | Market Commentary: Biosite boosted by rival bid; DaimlerChrysler driven up; Conseco climbs; Calpine rises
|
4/5/2007 | SS | Biosite receives unsolicited offer from Inverness Medical as Beckman Coulter deal moves forward
|
4/2/2007 | CV | Beckman Coulter plans to issue convertibles to help fund $1.55 billion Biosite acquisition
|
3/26/2007 | CV | Fitch puts Beckman Coulter on negative watch
|
3/26/2007 | SS | Beckman Coulter to acquire Biosite in $85-per-share tender offer
|
3/26/2007 | SS | Market Commentary: Biosite buyout lifts diagnostics firms; Rotech rises; Tribune up; Riviera gains; LSI, Agere slump
|
3/26/2007 | CV | S&P: Beckman Coulter on watch
|
3/26/2007 | CV | Moody's may downgrade Beckman Coulter
|
12/12/2006 | CV | New Issue: Beckman Coulter sells $600 million of 30-year convertibles cheaper than talk, at 2.5%, up 25%
|
12/12/2006 | CV | Market Commentary: ON lights up on debut; Beckman Coulter gains on cheap pricing; Acquicor rises; Cadence launches deal
|
12/11/2006 | CV | Market Commentary: Continental, UAL climb on merger speculation; Beckman Coulter quiet as talk cheapened; ON plans deal
|
12/11/2006 | CV | Beckman Coulter to price $525 million 30-year convertibles, talked at 2.5%-2.625%, up 27.5%
|
12/11/2006 | CV | Moody's rates Beckman Coulter convertible Baa3
|
12/11/2006 | CV | Fitch rates Beckman Coulter convertible BBB
|
10/17/2006 | BT | Moody's affirms Beckman Coulter
|
10/4/2006 | BT | Fitch cuts Beckman Coulter to BBB
|
10/3/2006 | BT | S&P affirms Beckman Coulter
|
8/2/2006 | BT | Beckman Coulter at outperform by RBC
|
7/31/2006 | BT | Digene wins HPV patent dispute with Beckman Coulter in arbitration
|
7/26/2006 | BT | RBC makes Whistle Stop Tour at AACC
|
7/25/2006 | BT | Beckman Coulter at outperform by RBC
|
7/17/2006 | BT | Beckman Coulter acquires in vitro diagnostics product license from Roche for $27.5 million
|
7/11/2006 | BT | Beckman at outperform by RBC
|
1/24/2006 | BT | Moody's affirms Beckman Coulter
|
10/7/2005 | BT | Beckman Coulter to acquire Diagnostic Systems Laboratories
|
11/9/2001 | CV | Fitch sees combined Enron, Dynegy at mid BBB
|
11/9/2001 | HY | Fitch sees combined Enron, Dynegy at mid BBB
|